Clinical trials
Phase 3 Pregnancy Complications trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Harvard School of Public Health (HSPH) | 2 |
| Ottawa Hospital Research Institute | 2 |
| American University of Beirut Medical Center | 1 |
| Amsterdam UMC | 1 |
| Duchesnay Inc. | 1 |
| Hospital de Cruces | 1 |
| Karolinska University Hospital | 1 |
| McMaster University | 1 |
| Melanie Maykin, MD | 1 |
| Rigshospitalet, Denmark | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pregnancy Complications | 17 |
| Pre-Eclampsia | 4 |
| Premature Birth | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| HIV Infections | 2 |
| Hyperemesis Gravidarum | 2 |
| Hypertension, Pregnancy-Induced | 2 |
| Abortion, Spontaneous | 1 |
| Anemia, Sickle Cell | 1 |
| Breech Presentation | 1 |
Trials
Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.